Yekaterina Chudnovsky's most recent trade in Elicio Therapeutics Inc. was a trade of 3,500,573 Common Stock done at an average price of $5.8 . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | 05 Mar 2025 | 3,500,573 | 5,416,212 | - | 5.8 | 20,338,329 | Common Stock | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | 05 Mar 2025 | 3,442,341 | 0 | - | - | Convertible Note (convertible into Common Stock) | ||
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Aug 2024 | 3,442,341 | 3,442,341 | - | - | Convertible Note (convertible into Common Stock) | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 1,600,000 | 1,600,000 | - | - | Pre-Funded Warrants | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Jun 2024 | 1,600,000 | 1,600,000 | - | - | Common Warrants | |
Immix Biopharma Inc | Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Mar 2024 | 1,032,702 | 1,032,702 | - | - | Pre-Funded Common Stock Purchase Warrant | |
Elicio Therapeutics Inc. | Chudnovsky Yekaterina | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
Elicio Therapeutics Inc. | Yekaterina Chudnovsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.81 per share. | 22 Dec 2023 | 1,213,000 | 1,915,639 | - | 5.8 | 7,047,530 | Common Stock |
Immix Biopharma Inc | Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Immix Biopharma Inc | Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2023 | 16,670 | 16,670 | - | - | Stock Option (Right to Buy) |